ARQT - CIK 0001787306
Arcutis Biotherapeutics, Inc. (ARQT) reported revenue of $376.07M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $376.07M | +91.3% |
| FY 2024 | $196.54M | +229.7% |
| FY 2023 | $59.61M | +1517.1% |
| FY 2022 | $3.69M | - |
| FY 2021 | $0.00 | - |
| FY 2020 | $0.00 | - |
Arcutis Biotherapeutics, Inc. (ARQT) reported revenue of $376.07M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Arcutis Biotherapeutics, Inc.'s revenue grew from $0.00 to $376.07M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.